Reprogramming towards endothelial cells for vascular regeneration

Genes and Diseases

Volumn 3, Issue 3, 2016, Pages 186-197

  Hong, Xuechong ^a   Le Bras, Alexandra ^a   Margariti, Andriana ^b   Xu, Qingbo ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Atherosclerosis; Cell reprogramming; Endothelial cells; Endothelial regeneration; iPS cells; Stem cells

Indexed keywords

NOTCH RECEPTOR; TRANSCRIPTION FACTOR;

ANGIOGENESIS; BLOOD VESSEL FUNCTION; CELL DIFFERENTIATION; CELL LINEAGE; CELL PLASTICITY; CELL REGENERATION; COMPARATIVE STUDY; ENDOTHELIAL DYSFUNCTION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; INDUCED PLURIPOTENT STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; VASCULAR DISEASE; VASCULAR ENDOTHELIAL CELL;

EID: 84983134148     PISSN: None     EISSN: 23523042     Source Type: Journal    
DOI: 10.1016/j.gendis.2016.02.003     Document Type: Review

References (91)

1. 1 Deanfield, J.E., Halcox, J.P., Rabelink, T.J., Endothelial function and dysfunction: testing and clinical relevance. Circulation 115 (2007), 1285–1295.
2. 2 Asahara, T., Murohara, T., Sullivan, A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997), 964–967.
3. 3 Fadini, G.P., Losordo, D., Dimmeler, S., Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 110 (2012), 624–637.
4. 4 Yamashita, J., Itoh, H., Hirashima, M., et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408 (2000), 92–96.
5. 5 Ferreira, L.S., Gerecht, S., Shieh, H.F., et al. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ Res 101 (2007), 286–294.
6. 6 Levenberg, S., Ferreira, L.S., Chen-Konak, L., Kraehenbuehl, T.P., Langer, R., Isolation, differentiation and characterization of vascular cells derived from human embryonic stem cells. Nat Protoc 5 (2010), 1115–1126.
7. 7 Cho, S.W., Moon, S.H., Lee, S.H., et al. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 116 (2007), 2409–2419.
8. 8 Prado-Lopez, S., Conesa, A., Arminan, A., et al. Hypoxia promotes efficient differentiation of human embryonic stem cells to functional endothelium. Stem Cells 28 (2010), 407–418.
9. 9 Takahashi, K., Tanabe, K., Ohnuki, M., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007), 861–872.
10. 10 Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006), 663–676.
11. 11 Yu, J., Vodyanik, M.A., Smuga-Otto, K., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007), 1917–1920.
12. 12 Carmeliet, P., Developmental biology. One cell, two fates. Nature, 408, 2000 43, 45.
13. 13 Dejana, E., Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 5 (2004), 261–270.
14. 14 Michel, T., Vanhoutte, P.M., Cellular signaling and NO production. Pflugers Arch Eur J Physiol 459 (2010), 807–816.
15. 15 Tousoulis, D., Kampoli, A.M., Tentolouris, C., Papageorgiou, N., Stefanadis, C., The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 10 (2012), 4–18.
16. 16 Pober, J.S., Sessa, W.C., Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7 (2007), 803–815.
17. 17 van Hinsbergh, V.W., Endothelium – role in regulation of coagulation and inflammation. Semin Immunopathol 34 (2012), 93–106.
18. 18 Landmesser, U., Hornig, B., Drexler, H., Endothelial function: a critical determinant in atherosclerosis?. Circulation 109:21 suppl 1 (2004), II27–33.
19. 19 Endemann, D.H., Schiffrin, E.L., Endothelial dysfunction. J Am Soc Nephrol JASN 15 (2004), 1983–1992.
20. 20 Hagensen, M.K., Vanhoutte, P.M., Bentzon, J.F., Arterial endothelial cells: still the craftsmen of regenerated endothelium. Cardiovasc Res 95 (2012), 281–289.
21. 21 Hagensen, M.K., Raarup, M.K., Mortensen, M.B., et al. Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine arterial injury. Cardiovasc Res 93 (2012), 223–231.
22. 22 Hirase, T., Node, K., Endothelial dysfunction as a cellular mechanism for vascular failure. Am J Physiol Heart Circ Physiol 302 (2012), H499–H505.
23. 23 Yamanaka, S., Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 10 (2012), 678–684.
24. 24 Choi, K.D., Yu, J., Smuga-Otto, K., et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27 (2009), 559–567.
25. 25 Taura, D., Sone, M., Homma, K., et al. Induction and isolation of vascular cells from human induced pluripotent stem cells – brief report. Arterioscler Thromb Vasc Biol 29 (2009), 1100–1103.
26. 26 Rufaihah, A.J., Huang, N.F., Jame, S., et al. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol 31 (2011), e72–79.
27. 27 Wong, W.T., Huang, N.F., Botham, C.M., Sayed, N., Cooke, J.P., Endothelial cells derived from nuclear reprogramming. Circ Res 111 (2012), 1363–1375.
28. 28 Grabel, L., Prospects for pluripotent stem cell therapies: into the clinic and back to the bench. J Cell Biochem 113 (2012), 381–387.
29. 29 Pera, M.F., Stem cells: the dark side of induced pluripotency. Nature 471 (2011), 46–47.
30. 30 Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J., Melton, D.A., In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455 (2008), 627–632.
31. 31 Ieda, M., Fu, J.D., Delgado-Olguin, P., et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142 (2010), 375–386.
32. 32 Qian, L., Huang, Y., Spencer, C.I., et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485 (2012), 593–598.
33. 33 Vierbuchen, T., Ostermeier, A., Pang, Z.P., Kokubu, Y., Sudhof, T.C., Wernig, M., Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463 (2010), 1035–1041.
34. 34 Huang, P., Zhang, L., Gao, Y., et al. Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell 14 (2014), 370–384.
35. 35 Efe, J.A., Hilcove, S., Kim, J., et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat Cell Biol 13 (2011), 215–222.
36. 36 Ginsberg, M., James, D., Ding, B.S., et al. Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFbeta suppression. Cell 151 (2012), 559–575.
37. 37 Dejana, E., Taddei, A., Randi, A.M., Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis. Biochim Biophys Acta 1775 (2007), 298–312.
38. 38 Han, J.K., Chang, S.H., Cho, H.J., et al. Direct conversion of adult skin fibroblasts to endothelial cells by defined factors. Circulation 130 (2014), 1168–1178.
39. 39 Morita, R., Suzuki, M., Kasahara, H., et al. ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells. Proc Natl Acad Sci U. S. A 112 (2015), 160–165.
40. 40 Cahan, P., Li, H., Morris, S.A., Lummertz da Rocha, E., Daley, G.Q., Collins, J.J., CellNet: network biology applied to stem cell engineering. Cell 158 (Aug 14 2014), 903–915.
41. 41 Kurian, L., Sancho-Martinez, I., Nivet, E., et al. Conversion of human fibroblasts to angioblast-like progenitor cells. Nat Methods 10 (2013), 77–83.
42. 42 Margariti, A., Winkler, B., Karamariti, E., et al. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. Proc Natl Acad Sci U. S. A 109 (2012), 13793–13798.
43. 43 Karamariti, E., Margariti, A., Winkler, B., et al. Smooth muscle cells differentiated from reprogrammed embryonic lung fibroblasts through DKK3 signaling are potent for tissue engineering of vascular grafts. Circ Res 112 (2013), 1433–1443.
44. 44 Li, J., Huang, N.F., Zou, J., et al. Conversion of human fibroblasts to functional endothelial cells by defined factors. Arterioscler Thromb Vasc Biol 33 (2013), 1366–1375.
45. 45 Bar-Nur, O., Verheul, C., Sommer, A.G., et al. Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage. Nat Biotechnol 33 (2015), 761–768.
46. 46 Maza, I., Caspi, I., Zviran, A., et al. Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors. Nat Biotechnol 33 (2015), 769–774.
47. 47 Xu, J., Du, Y., Deng, H., Direct lineage reprogramming: strategies, mechanisms, and applications. Cell Stem Cell 16 (2015), 119–134.
48. 48 Sayed, N., Wong, W.T., Ospino, F., et al. Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity. Circulation 131 (2015), 300–309.
49. 49 Campagnolo, P., Wong, M.M., Xu, Q., Progenitor cells in arteriosclerosis: good or bad guys?. Antioxid Redox Signal 15 (2011), 1013–1027.
50. 50 Le Bras, A., Vijayaraj, P., Oettgen, P., Molecular mechanisms of endothelial differentiation. Vasc Med 15 (2010), 321–331.
51. 51 Ferguson, J.E. 3rd, Kelley, R.W., Patterson, C., Mechanisms of endothelial differentiation in embryonic vasculogenesis. Arterioscler Thromb Vasc Biol 25 (2005), 2246–2254.
52. 52 Hochedlinger, K., Plath, K., Epigenetic reprogramming and induced pluripotency. Development 136 (2009), 509–523.
53. 53 Samavarchi-Tehrani, P., Golipour, A., David, L., et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 7 (2010), 64–77.
54. 54 Golipour, A., David, L., Liu, Y., et al. A late transition in somatic cell reprogramming requires regulators distinct from the pluripotency network. Cell Stem Cell 11 (2012), 769–782.
55. 55 Polo, J.M., Anderssen, E., Walsh, R.M., et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 151 (2012), 1617–1632.
56. 56 Buganim, Y., Faddah, D.A., Jaenisch, R., Mechanisms and models of somatic cell reprogramming. Nat Rev Genet 14 (2013), 427–439.
57. 57 Soufi, A., Donahue, G., Zaret, K.S., Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell 151 (2012), 994–1004.
58. 58 Papp, B., Plath, K., Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape. Cell Res 21 (2011), 486–501.
59. 59 Cowan, C.E., Kohler, E.E., Dugan, T.A., Mirza, M.K., Malik, A.B., Wary, K.K., Kruppel-like factor-4 transcriptionally regulates VE-cadherin expression and endothelial barrier function. Circ Res 107 (2010), 959–966.
60. 60 Hamik, A., Lin, Z., Kumar, A., et al. Kruppel-like factor 4 regulates endothelial inflammation. J Biol Chem 282 (May 4 2007), 13769–13779.
61. 61 Campagnolo, P., Tsai, T.N., Hong, X., et al. c-Kit+ progenitors generate vascular cells for tissue-engineered grafts through modulation of the Wnt/Klf4 pathway. Biomaterials 60 (2015), 53–61.
62. 62 Li, R., Liang, J., Ni, S., et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 7 (2010), 51–63.
63. 63 Liao, B., Bao, X., Liu, L., et al. MicroRNA cluster 302-367 enhances somatic cell reprogramming by accelerating a mesenchymal-to-epithelial transition. J Biol Chem 286 (2011), 17359–17364.
64. 64 Hansson, J., Rafiee, M.R., Reiland, S., et al. Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency. Cell Rep 2 (2012), 1579–1592.
65. 65 Buganim, Y., Itskovich, E., Hu, Y.C., et al. Direct reprogramming of fibroblasts into embryonic Sertoli-like cells by defined factors. Cell Stem Cell 11 (2012), 373–386.
66. 66 Muraoka, N., Yamakawa, H., Miyamoto, K., et al. MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. EMBO J 33 (2014), 1565–1581.
67. 67 Bray, S.J., Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7 (2006), 678–689.
68. 68 Artavanis-Tsakonas, S., Muskavitch, M.A., Notch: the past, the present, and the future. Curr Top Dev Biol 92 (2010), 1–29.
69. 69 Fleming, R.J., Structural conservation of Notch receptors and ligands. Semin Cell Dev Biol 9 (1998), 599–607.
70. 70 Xue, Y., Gao, X., Lindsell, C.E., et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 8 (1999), 723–730.
71. 71 Li, L., Krantz, I.D., Deng, Y., et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 16 (1997), 243–251.
72. 72 Oda, T., Elkahloun, A.G., Pike, B.L., et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 16 (1997), 235–242.
73. 73 Kamath, B.M., Spinner, N.B., Emerick, K.M., et al. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation 109 (2004), 1354–1358.
74. 74 Benedito, R., Roca, C., Sorensen, I., et al. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137 (2009), 1124–1135.
75. 75 Kwon, S.M., Eguchi, M., Wada, M., et al. Specific Jagged-1 signal from bone marrow microenvironment is required for endothelial progenitor cell development for neovascularization. Circulation 118 (2008), 157–165.
76. 76 Chen, H.F., Huang, C.H., Liu, C.J., et al. Twist1 induces endothelial differentiation of tumour cells through the Jagged1-KLF4 axis. Nat Commun, 5, 2014, 4697.
77. 77 Lee, J.B., Werbowetski-Ogilvie, T.E., Lee, J.H., et al. Notch-HES1 signaling axis controls hemato-endothelial fate decisions of human embryonic and induced pluripotent stem cells. Blood 122 (2013), 1162–1173.
78. 78 Iso, T., Kedes, L., Hamamori, Y., HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 194 (2003), 237–255.
79. 79 Xu, J., Liu, X., Chen, J., et al. Simvastatin enhances bone marrow stromal cell differentiation into endothelial cells via notch signaling pathway. Am J Physiology Cell Physiol 296 (2009), C535–C543.
80. 80 Schober, A., Nazari-Jahantigh, M., Wei, Y., et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med 20 (2014), 368–376.
81. 81 Al-Hasani, K., Pfeifer, A., Courtney, M., et al. Adult duct-lining cells can reprogram into beta-like cells able to counter repeated cycles of toxin-induced diabetes. Dev Cell 26 (2013), 86–100.
82. 82 Baeyens, L., Lemper, M., Leuckx, G., et al. Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice. Nat Biotechnol 32 (2014), 76–83.
83. 83 Raval, Z., Losordo, D.W., Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. Circ Res 112 (2013), 1288–1302.
84. 84 Annex, B.H., Therapeutic angiogenesis for critical limb ischaemia. Nat Rev Cardiol 10 (2013), 387–396.
85. 85 Lippmann, E.S., Azarin, S.M., Kay, J.E., et al. Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Nat Biotechnol 30 (2012), 783–791.
86. 86 Nolan, D.J., Ginsberg, M., Israely, E., et al. Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration. Dev Cell 26 (2013), 204–219.
87. 87 Wong, M.M., Hong, X., Karamariti, E., Hu, Y., Xu, Q., Generation and grafting of tissue-engineered vessels in a mouse model. J Vis Exp, 2015, e52565, 10.3791/52565 (2015).
88. 88 Santulli, G., Wronska, A., Uryu, K., et al. A selective microRNA-based strategy inhibits restenosis while preserving endothelial function. J Clin Invest 124 (2014), 4102–4114.
89. 89 Morris, S.A., Cahan, P., Li, H., et al. Dissecting engineered cell types and enhancing cell fate conversion via CellNet. Cell 158 (2014), 889–902.
90. 90 Rackham, O.J., Firas, J., Fang, H., et al. A predictive computational framework for direct reprogramming between human cell types. Nat Genet 48 (2016), 331–335.
91. 91 D'Alessio, A.C., Fan, Z.P., Wert, K.J., et al. A systematic approach to identify candidate transcription factors that control cell identity. Stem Cell Rep 5 (2015), 763–775.